Article Details
Retrieved on: 2021-01-12 18:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
One strategy for leveraging NKs is to use monoclonal antibodies to target IRs. This approach has shown benefits in other types of cancers, the authors ...
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here